Realize the Clinical Potential of Bispecific Therapeutics

This week's FierceBiotech is brought to you by Hanson Wade.

If you are having trouble viewing this email click here to see the online version

Dear Reader,

The 8th Annual World Bispecific Summit is devoted entirely to providing you with technical insights from every stage of the discovery and development process, enabling you to realize the clinical potential of your bispecific therapeutics.

Uniting the industry leaders pioneering progress in this space, this summit will enable you to:

Integrate lessons learned from the clinic into your own work by understanding the key factors involved in the successful clinical progression of candidate bispecifics with insights from Abbvie
Optimize synergistic target selection by understanding how probability of selection success can be improved through the strategic design of libraries, with Bristol-Myers Squibb
Understand the true value and utility of formats with head-to-head comparisons of key format characteristics, enabling you to enhance your future format design with experts from Eli Lilly, Roche, Jounce and Zymeworks
Combine checkpoint pathways effectively by investigating the rationale and mechanistic understanding behind checkpoint-targeting bispecifics, with insights from Macrogenics
Pioneer bispecifics beyond oncology by investigating the unique requirements and value of bispecifics in targeting the Ebola virus, developed by Albert Einstein College of Medicine

Download the full program to view the full speaker faculty and discussion topics.

Join your peers at this uniquely focused meeting to gain tangible, actionable lessons that will enhance your bispecific development programs today.

Register as a group of 3 to receive 10% discount, enabling your team to gain from the 2 streams of content, series of pre-conference workshops and unparalleled networking opportunities. Enquire about registering as a group.

I look forward to meeting you in Boston.

Kind regards,

David Snowdon

Program Director

Hanson Wade

Want to reach 150,000+ FierceBiotech subscribers with your own message?
Contact aalcover@fiercemarkets.com or call 202-824-5074.

About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe.

FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400
Washington, DC 20036